Cirillo A, Marinelli D, Romeo U, Messineo D, et al. Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis. BMC Cancer 2024;24:430.
PMID: 38589857